Brief: Spruce Biosciences Reports Third Quarter 2022 Financial Results, Provides Corporate Updates
Nov 10 (Reuters) - Spruce Biosciences Inc SPRB.O :
* SPRUCE BIOSCIENCES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATES
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.48
* CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS AS OF
SEPTEMBER 30, 2022, WERE $90.4 MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.54 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw8plrg9a
Further company coverage: SPRB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spruce Biosciences
See all newsSpruce Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Spruce Biosciences Q2 net loss widens on higher expenses
Spruce Biosciences, Inc. expected to post a loss of $5.80 a share - Earnings Preview
Brief: Spruce Biosciences Appoints Adrian Quartel, M.D., Ffpm, As Chief Medical Officer
Brief: Spruce Biosciences Announces Data Presentation At The 18Th International MPS Symposium